Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Oncol. Nov 24, 2024; 15(11): 1404-1411
Published online Nov 24, 2024. doi: 10.5306/wjco.v15.i11.1404
Table 2 Comparison of short-term efficacy, n (%)

ORR
DCR
APS + GS (n = 41)21 (51.22)23 (56.10)
GS regimen (n = 56)17 (30.36)20 (35.71)
χ2 value4.3233.985
P value0.0380.046